Dominant-negative TP53 mutations potentiated by the HSF1-regulated proteostasis network

Rebecca M. Sebastian,Jessica E. Patrick,Tiffani Hui,David R. Amici,Andrew O. Giacomelli,Vincent L. Butty,William C. Hahn,Marc L. Mendillo,Yu-Shan Lin,Matthew D. Shoulders

DOI: https://doi.org/10.1101/2024.11.01.621414

2024-11-03

Abstract:Protein mutational landscapes are sculpted by the impacts of the resulting amino acid substitutions on the proteins stability and folding or aggregation kinetics. These properties can, in turn, be modulated by the composition and activities of the cellular proteostasis network. Heat shock factor 1 (HSF1) is the master regulator of the cytosolic and nuclear proteostasis networks, dynamically tuning the expression of cytosolic and nuclear chaperones and quality control factors to meet demand. Chronic increases in HSF1 levels and activity are prominent hallmarks of cancer cells. One plausible explanation for this observation is that the consequent upregulation of proteostasis factors could biophysically facilitate the acquisition of oncogenic mutations. Here, we experimentally evaluate the impacts of chronic HSF1 activation on the mutational landscape accessible to the quintessential oncoprotein p53. Specifically, we apply quantitative deep mutational scanning of p53 to assess how HSF1 activation shapes the mutational pathways by which p53 can escape cytotoxic pressure conferred by the small molecule nutlin-3, which is a potent antagonist of the p53 negative regulator MDM2. We find that activation of HSF1 broadly increases the fitness of dominant-negative substitutions within p53. This effect of HSF1 activation was particularly notable for non-conservative, biophysically unfavorable amino acid substitutions within buried regions of the p53 DNA-binding domain. These results indicate that chronic HSF1 activation profoundly shapes the oncogenic mutational landscape, preferentially supporting the acquisition of cancer-associated substitutions that are biophysically destabilizing. Along with providing the first experimental and quantitative insights into how HSF1 influences oncoprotein mutational spectra, these findings also implicate HSF1 inhibition as a strategy to reduce the accessibility of mutations that drive chemo-therapeutic resistance and metastasis.

Molecular Biology

What problem does this paper attempt to address?

The core problem that this paper attempts to solve is: **How does the chronic activation of heat shock factor 1 (HSF1) affect the mutation landscape of tumor protein p53, especially how does it support the accumulation of those unstable mutations that lead to cancer?** Specifically, the researchers experimentally evaluated the effect of HSF1 activation on p53 mutation pathways that enable p53 to escape the cytotoxic pressure exerted by the small molecule nutlin - 3. Nutlin - 3 is a potent antagonist of MDM2, a negative regulator of p53. The study found that the activation of HSF1 significantly increased the fitness of dominant - negative mutations in p53, especially for non - conserved, biophysically unfavorable amino acid substitutions in the internal region of the p53 DNA - binding domain. These results indicate that the chronic activation of HSF1 profoundly shapes the landscape of oncogenic mutations, especially supporting the acquisition of those biophysically unstable cancer - related mutations. In addition, these findings also suggest that HSF1 inhibition may be an effective strategy to reduce the acquisition of mutations for chemotherapy resistance and metastasis.

Dominant-negative TP53 mutations potentiated by the HSF1-regulated proteostasis network

The heat-shock, or HSF1-mediated proteotoxic stress, response in cancer: from proteomic stability to oncogenesis

Mutant p53 as a guardian of the cancer cell

Mutant p53 gains oncogenic functions through a chromosomal instability-induced cytosolic DNA response

Network effect of Wt-mutant p53 interactions and implications on p53 gene therapy.

Abstract 2585: Mutant P53 Gains Oncogenic Functions Through a Cytosolic DNA Response

Heat Shock Proteins and HSF1 in Cancer

Mutant P53 in the formation and progression of the tumor microenvironment: Friend or foe

Zinc shapes the folding landscape of p53 and establishes a pathway for reactivating structurally diverse cancer mutants

Mutant p53 improves cancer cells’ resistance to endoplasmic reticulum stress by sustaining activation of the UPR regulator ATF6

Gain of Function of Mutant P53 by Coaggregation with Multiple Tumor Suppressors

Targeting mutant p53 stabilization for cancer therapy

Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability

Mutant p53 in cancer therapy-the barrier or the path.

Differential Gain-of-Function Activity of Three P53 Hotspot Mutants in Vivo

p53 mutants cooperate with HIF-1 in transcriptional regulation of extracellular matrix components to promote tumor progression

Integrating mutation data and structural analysis of the TP53 tumor‐suppressor protein

Cross-talk between mutant p53 and p62/SQSTM1 augments cancer cell migration by promoting the degradation of cell adhesion proteins

Proteasome inhibition paradoxically degrades gain-of-function mutant p53 R273H in NSCLC and could have therapeutic implications

Fundamental immune-oncogenicity trade-offs define driver mutation fitness

Mutant p53 in cancer: from molecular mechanism to therapeutic modulation